Evidence map›Paper›PMID 19445956›Full record

ArticleJournal of molecular biology2009

RNA dimerization promotes PKR dimerization and activation.

Laurie A Heinicke, C Jason Wong, Jeffrey Lary, Subba Rao Nallagatla, Amy Diegelman-Parente, Xiaofeng Zheng, James L Cole, Philip C Bevilacqua

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 77 citations in OpenAlex.

  1. Structural insights into HRI kinase activity and inhibition.Biochemical Society transactions · 2026
    Review
  2. Optimized tRNA structure-seq reveals robust tRNA secondary structures inbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Activation of PKR by a short-hairpin RNA.bioRxiv : the preprint server for biology · 2024
    Article
  7. Review
  8. RNA recognition by PKR during DNA virus infection.Journal of medical virology · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Cellular origins of dsRNA, their recognition and consequences.Nature reviews. Molecular cell biology · 2022
    Review
  13. Article
  14. Review
  15. Inhibition of PKR by Viruses.Frontiers in microbiology · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Laurie A HeinickeDepartment of Chemistry, Pennsylvania State University, University Park, 16802, USA.
C Jason Wong
Jeffrey Lary
Subba Rao Nallagatla
Amy Diegelman-Parente
Xiaofeng Zheng
James L Cole
Philip C Bevilacqua
Pennsylvania State University · USUniversity of Connecticut · USPeking University · CN

Funding

Mechanism for Activation of the Antiviral Kinase PKRR01AI053615 · NIAID · UNIVERSITY OF CONNECTICUT STORRS · PI COLE, JAMES L · 2004 to 2016
$3.9M
Regulation of PKR by Novel RNA MotifsR01GM058709 · NIGMS · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI BEVILACQUA, PHILIP C · 1999 to 2012
$2.8M
NIAID NIH HHS AI-53615NIAID NIH HHS R01 AI053615NIGMS NIH HHS GM-58709NIGMS NIH HHS R01 GM058709
6 · The paper itself

Abstract

The double-stranded RNA (dsRNA)-activated protein kinase [protein kinase R (PKR)] plays a major role in the innate immune response in humans. PKR binds dsRNA non-sequence specifically and requires a minimum of 15-bp dsRNA for one protein to bind and 30-bp dsRNA to induce protein dimerization and activation by autophosphorylation. PKR phosphorylates eukaryotic initiation factor 2alpha, a translation initiation factor, resulting in the inhibition of protein synthesis. We investigated the mechanism of PKR activation by an RNA hairpin with a number of base pairs intermediate between these 15- to 30-bp limits: human immunodeficiency virus type 1 transactivation-responsive region (TAR) RNA, a 23-bp hairpin with three bulges that is known to dimerize. TAR monomers and dimers were isolated from native gels and assayed for RNA and protein dimerization to test whether RNA dimerization affects PKR dimerization and activation. To modulate the extent of dimerization, we included TAR mutants with different secondary features. Native gel mixing experiments and analytical ultracentrifugation indicate that TAR monomers bind one PKR monomer and that TAR dimers bind two or three PKRs, demonstrating that RNA dimerization drives the binding of multiple PKR molecules. Consistent with functional dimerization of PKR, TAR dimers activated PKR while TAR monomers did not, and RNA dimers with fewer asymmetrical secondary-structure defects, as determined by enzymatic structure mapping, were more potent activators. Thus, the secondary-structure defects in the TAR RNA stem function as antideterminants to PKR binding and activation. Our studies support that dimerization of a 15- to 30-bp hairpin RNA, which effectively doubles its length, is a key step in driving activation of PKR and provide a model for how RNA folding can be related to human disease.

Indexed as

DimerizationBase SequenceeIF-2 KinaseHIV-1HIV Long Terminal RepeatHumansModels, BiologicalModels, MolecularMolecular Sequence DataNucleic Acid ConformationProtein BindingRNA, Double-StrandedRNA, ViraleIF-2 KinaseRNA, Double-StrandedRNA, Viral

Identifiers

PMID19445956
PMCPMC2763119
OpenAlexW2104164035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.